Please assess the completion status of the following clinical trial:

Trial Title: Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Completed UP1002 or 733-005.~2. Willing and able to provide consent and comply with the requirements of the study protocol.~Exclusion Criteria:~1. Met any of the stopping rules for study discontinuation at the final visit of study UP1002 or 733-005.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- lomitapide (Type: EXPERIMENTAL): Maximum tolerated dose of lomitapide in addition to existing lipid lowering therapy including plasmapheresis or lipid apheresis.

Based on this trial design, predict the completion outcome and termination type (if applicable).